Pharmafile Logo
Pharmafocus logo
Advanced Search

Press release

Showing 15 posts of 581 posts found.

Modus Therapeutics announces positive topline data from its Phase 1b LPS provocation study evaluating the potential of sevuparin for treatment of sepsis

February 22, 2023
Business Services

STOCKHOLM, SWEDEN – 21 February 2023: Modus Therapeutics AB (“Modus”), a company developing innovative treatments for patients with major unmet …

News
Press release

Beckley Psytech receives FDA Investigational New Drug (IND) approval for Phase IIb study of BPL-003, a novel synthetic formulation of 5-MeO-DMT (Mebufotenin)

February 21, 2023
Business Services

Oxford, United Kingdom – 21 FEBRUARY 2023 – Beckley Psytech Ltd, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric …

News
Press release

AstraZeneca and MSD present final results of key secondary overall survival endpoint from Phase III PROpel trial at ASCO GU Cancers Symposium

February 20, 2023
Business Services

Results from the final prespecified overall survival (OS) analysis of the PROpel Phase III trial in metastatic castration-resistant prostate cancer …

News
Press release

SMC recommends Opdivo® (nivolumab) for use post-surgery in specific urothelial cancer patients

February 20, 2023
Business Services

(Uxbridge, Middlesex, 13 February 2023) – The Scottish Medicines Consortium (SMC) has accepted Bristol Myers Squibb’s (BMS’) nivolumab for the …

News
Press release

Janssen Presents Updated Data Demonstrating Improved Outcomes from the Use of Niraparib in Combination with Abiraterone Acetate Plus Prednisone as a First-Line Therapy in Patients with BRCA-Positive Metastatic CastrationResistant Prostate Cance

February 20, 2023
Business Services

BEERSE, BELGIUM, 16 February 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced updated results from the …

News
Press release

UK pharma packaging giant Origin celebrates its 60th anniversary

February 13, 2023
Business Services

13th FEBRUARY 2023, HULL, UK: Leading UK pharmaceutical packaging and solutions provider, Origin, is celebrating its 60th anniversary.   Origin …

News
Press release

CYDAR MEDICAL RAISES $11.5M (£9.3M) IN SERIES A FUNDING ROUND

February 13, 2023
Business Services

CAMBRIDGE, UNITED KINGDOM, 13 FEBRUARY 2023 – Cydar Medical (“Cydar” or “the Company”) a global, cloud-based surgical software company, announces …

News
Press release

The First Women in Leadership Network to Support Diversity, Equality and Inclusion across the Life Sciences Industry launched in Denmark

February 9, 2023
Business Services

9 February 2023, Denmark: Women in Life Science Denmark (WiLD), an inspiring and science-centric not-for-profit network for women in senior …

News
Press release

Redx Provides Progress Update on RXC007 Clinical Programme

February 9, 2023
Business Services

Alderley Park, UK, 9 February 2023 Redx (AIM:REDX), the clinical-stage biotechnology company focused on discovering and developing novel, small molecule, …

News
Press release

Sequana Medical announces 2022 Full Year Results and 2023 Outlook

February 9, 2023
Business Services

Ghent, Belgium – 09 February 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical”), a pioneer …

News
Press release

Availability of Sanofi’s Nexviadyme®▼(avalglucosidase alfa) provides NHS with new treatment for Pompe disease

February 8, 2023
Business Services

READING, ENGLAND – Wednesday 8th February 2023. Sanofi announced today that healthcare specialists and patients living with Pompe disease will …

News
Press release

Cell and Gene Therapy Catapult to play significant role in establishing one of the largest life sciences campuses in Europe

February 8, 2023
Business Services

London, 8th February 2023: The Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in …

News
Press release

Sequana Medical announces the successful completion of pre-clinical studies with its second-generation DSR product for congestive heart failure

February 8, 2023
Business Services

Ghent, Belgium – 08 February 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana

News
Press release

Sage Therapeutics and Biogen Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression

February 7, 2023
Business Services

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) announced the U.S. Food and Drug Administration (FDA) has accepted …

News
Press release

Oxford Science Enterprises strengthens Life Sciences investment team with appointment of Sanne de Jongh as Partner

February 7, 2023
Business Services

Oxford, UK: February 7, 2023 – Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build transformational businesses …

News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025